Neuronetics (STIM) Misses Q1 EPS by 4c; Offers FY23 Revenue Guidance

Neuronetics (NASDAQ: STIM) reported Q1 EPS of ($0.38), $0.04 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $16.71 million.

GUIDANCE:

Neuronetics sees FY2023 revenue of $68-73 million, versus the consensus of $68.7 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c